Why women choose compounded bioidentical hormone therapy: lessons from a qualitative study of menopausal decision-making

BACKGROUND: In recent years, compounded bioidentical hormone therapy (CBHT) has emerged as a popular alternative to manufactured, FDA approved hormone therapy (HT)—despite concerns within the medical community and the availability of new FDA approved “bioidentical” products. This study aims to chara...

Descripción completa

Detalles Bibliográficos
Autores principales: Thompson, Jennifer Jo, Ritenbaugh, Cheryl, Nichter, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5625649/
https://www.ncbi.nlm.nih.gov/pubmed/28969624
http://dx.doi.org/10.1186/s12905-017-0449-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5625649/
https://www.ncbi.nlm.nih.gov/pubmed/28969624
http://dx.doi.org/10.1186/s12905-017-0449-0

Ejemplares similares